erastin - Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Columbia University, Prolexys
Targeted ErbB4 receptor activation prevents D-galactose-induced neuronal senescence via inhibiting ferroptosis pathway. (PubMed, Front Pharmacol) - Feb 17, 2025 - "Additionally, E4A markedly ameliorated Erastin-induced ferroptosis in mouse hippocampal neuronal cells. Our findings suggest that targeted activation of ErbB4 receptor may be a viable strategy for treating neuronal senescence by inhibiting ferroptosis, thereby offering a potential therapeutic avenue for senescence-associated neurodegenerative diseases." 
Journal • CNS Disorders • CDKN1A • ERBB4 • GFAP • LMNB1
http://www.ncbi.nlm.nih.gov/pubmed/39959423
 
Chen-Meng Qiao; Chong Liu; Chun Cui; Ji-Ji Dao; Qian Li; Shuang-Xi Chen; Wei Zhang; Wei-Jiang Zhao; Yan-Qin Shen
 
Feb 17, 2025
 
Prev Next